Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × cobimetinib × Clear all

Sponsor

Conditions

Melanoma 9 Neoplasms 5 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Gastrointestinal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Microsatellite Unstable Colorectal Cancer 1 Lung Neoplasms 1 Lung Diseases 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡